Cody L. Fullenwider

Characterization of Aldehyde Oxidase Enzyme Activity in Cryopreserved Human Hepatocytes

J. Matthew Hutzler, Young-Sun Yang, Daniel Albaugh et al. · Drug Metabolism and Disposition · 2011 · 77 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Time-Dependent Inhibition and Estimation of CYP3A Clinical Pharmacokinetic Drug-Drug Interactions Using Plated Human Cell Systems

Daniel Albaugh, Cody L. Fullenwider, Michael B. Fisher et al. · Drug Metabolism and Disposition · 2012 · 21 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Predictive In Vitro-In Vivo Extrapolation for Time Dependent Inhibition of CYP1A2, CYP2C8, CYP2C9, CYP2C19, and CYP2D6 Using Pooled Human Hepatocytes, Human Liver Microsomes, and a Simple Mechanistic Static Model

Diane Ramsden, Elke S. Perloff, Andrea Whitcher‐Johnstone et al. · Drug Metabolism and Disposition · 2021 · 20 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Aryl 1,4-diazepane compounds as potent and selective CB2 agonists: Optimization of drug-like properties and target independent parameters

Renée Zindell, Edward R. Walker, John Scott et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 14 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Characterization of Correction Factors to Enable Assessment of Clinical Risk from In Vitro CYP3A4 Induction Data and Basic Drug-Drug Interaction Models

Diane Ramsden, Cody L. Fullenwider · European Journal of Drug Metabolism and Pharmacokinetics · 2022 · 13 citations · Full text

Medicine, Pharmacology, Toxicology +17